Friday, 19 Dec 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • House
  • VIDEO
  • ScienceAlert
  • White
  • man
  • Trumps
  • Watch
  • Season
  • Health
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Jim Cramer on New York Times: “I Like Their Case”
Economy

Jim Cramer on New York Times: “I Like Their Case”

Last updated: November 7, 2025 5:05 am
Share
Jim Cramer on New York Times: “I Like Their Case”
SHARE

The New York Times Company (NYSE: NYT) is a key player in the AI space, as highlighted by Jim Cramer in a recent episode. Cramer pointed out the company’s lucrative deals and ongoing legal battles, emphasizing the potential for profit through licensing data to AI platforms.

One such deal that Cramer mentioned is the multi-year licensing agreement between The New York Times and Amazon. This agreement allows Amazon to use NYT articles to train AI models, showcasing the value of the newspaper’s content in the digital age. The financial details of the deal were not disclosed, but Cramer noted that The New York Times stands to benefit significantly without any additional costs.

With a focus on producing and distributing news and information across digital, print, and audio platforms, The New York Times Company is a leader in the media industry. However, while NYT may be a solid investment choice, there are other AI stocks that offer even greater potential for growth and stability.

For investors seeking undervalued AI stocks with promising upside potential, exploring other options in the market may be beneficial. One such opportunity is detailed in a free report on the best short-term AI stock that could benefit from current economic trends.

In conclusion, The New York Times Company is positioned as a strong player in the AI space, with valuable content and strategic partnerships driving its success. Investors looking to capitalize on the AI market should consider all available options to maximize their returns.

For more financial insights and investment recommendations, be sure to check out the latest articles on Insider Monkey. Please note that this article is not intended as investment advice and is for informational purposes only.

See also  Steel pipped by Mystics | Otago Daily Times Online News
TAGGED:caseCramerJimtimesYork
Share This Article
Twitter Email Copy Link Print
Previous Article Reflections from the IPCC Plenary in Lima on the Road to COP30 Reflections from the IPCC Plenary in Lima on the Road to COP30
Next Article CPD Withholds Border Patrol Shooting Videos, Citing Probe of Chief Accused of Calling Off Cops CPD Withholds Border Patrol Shooting Videos, Citing Probe of Chief Accused of Calling Off Cops
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Did Pauly D Shave His Head? Jersey Shore Star Shares Video of Buzzcut

It’s official: the reigning prank war champion is back at it! Jersey Shore: Family Vacation…

October 13, 2025

ICE agents have new tools to track and ID people : NPR

Two ICE agents film the press using smartphones in the hallway outside the immigration court…

November 8, 2025

UTEP to Mountain West becomes potential conference realignment move amid Pac-12’s pursuit of 8 member schools

UTEP Miners are reportedly considering a move to the Mountain West conference in the next…

October 5, 2024

UEFA Champions League round of 16 storylines, schedule: How to watch UCL on Paramount+

The UEFA Champions League is back with the last 16 teams ready to battle it…

March 2, 2025

Recursion Pharmaceuticals Acquires Full Rights to REV102, Potential Oral Therapy for Rare Bone Disorder Hypophosphatasia

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) has made headlines as one of the best small cap AI…

July 21, 2025

You Might Also Like

Dollar Pushes Higher as Stocks Weaken
Economy

Dollar Pushes Higher as Stocks Weaken

December 18, 2025
Christmas Day Gasoline Prices Set To Fall To Covid-Era Levels
Economy

Christmas Day Gasoline Prices Set To Fall To Covid-Era Levels

December 18, 2025
“I Don’t Want You to Be in It”
Economy

“I Don’t Want You to Be in It”

December 18, 2025
Is Paramount Skydance Stock Underperforming the Nasdaq?
Economy

Is Paramount Skydance Stock Underperforming the Nasdaq?

December 18, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?